Pancreatic Cancer Research

ResearcherUniversity of Oklahoma Health Sciences CenterActive in the last 2 years

Chunbo He

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8250-1092; OpenAlex author ID A5079400102. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
37
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers · 2025: none · 2026: 2 papers

Papers 7

  1. KRAS Signaling Inhibition Induces a Targetable Metabolic Dependency on Lipophagy-Dependent Fatty Acid Oxidation in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-24-1984↗
  2. Systemic immunosuppression limits NK cell therapy efficacy in pancreatic cancer. Co-author DOI 10.1186/s12943-025-02340-8↗
  3. Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis. Co-author DOI 10.1038/s41556-024-01372-4↗
  4. Author Correction: Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 … Co-author DOI 10.1038/s41556-024-01417-8↗
  5. ENT1 blockade by CNX-774 overcomes resistance to DHODH inhibition in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2022.215981↗
  6. CD73 induces GM-CSF/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis. Co-author DOI 10.1038/s41388-021-02132-6↗
  7. Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression. Co-author DOI 10.1053/j.gastro.2021.06.045↗

Closest collaborators

The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ravi Kumar Thakur · 7 shared papers, 2021–2026 · strength 1.09
  2. Surendra Kumar Shukla · 7 shared papers, 2021–2026 · strength 1.09
  3. Pankaj Kumar Singh · 6 shared papers, 2021–2026 · strength 0.87
  4. Kamiya Mehla · 5 shared papers, 2021–2026 · strength 0.81
  5. Tuo Hu · 5 shared papers, 2021–2026 · strength 0.81
  6. Ryan J. King · 5 shared papers, 2021–2026 · strength 0.71
  7. Sai Sundeep Kollala · 4 shared papers, 2023–2026 · strength 0.66
  8. Nina V. Chaika · 5 shared papers, 2021–2024 · strength 0.65
  9. Scott E. Mulder · 5 shared papers, 2021–2024 · strength 0.65
  10. Michael Anthony Hollingsworth · 4 shared papers, 2022–2026 · strength 0.62
  11. Susanna Varkey Ulahannan · 3 shared papers, 2024–2026 · strength 0.50
  12. Divya Murthy · 4 shared papers, 2021–2024 · strength 0.48
  13. Kuldeep Singh Attri · 4 shared papers, 2021–2024 · strength 0.48
  14. Aneesha Dasgupta · 3 shared papers, 2022–2024 · strength 0.40
  15. Paul M. Grandgenett · 3 shared papers, 2022–2024 · strength 0.40
  16. Rosa F. Hwang · 2 shared papers, 2024 · strength 0.28
  17. Ajay Jain · 2 shared papers, 2024 · strength 0.28
  18. Vikrant Rai · 2 shared papers, 2024 · strength 0.28
  19. Robert Powers · 2 shared papers, 2024 · strength 0.28
  20. Teklab Gebregiworgis · 2 shared papers, 2024 · strength 0.28
  21. Joshua J. Souchek · 2 shared papers, 2024 · strength 0.28
  22. Barish H. Edil · 2 shared papers, 2024 · strength 0.28
  23. Kathryn Elaine Wellen · 2 shared papers, 2024 · strength 0.28
  24. Amarnath (Amar) Natarajan · 2 shared papers, 2024 · strength 0.28
  25. Nicholas James Mullen · 2 shared papers, 2021–2023 · strength 0.25

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.